Delivery Order SPE2DB20D9127-SPE2DB24FPRD6

Award Date 8/5/24
Potential Completion Date 8/26/24
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $42,881.40, is a delivery order to provide NEXPLANON 68 MG IMPLANTS. The contract has a firm fixed-price pricing type and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA valued...
This federal contract award, valued at $4,288.14, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,185,173 units of the NEXPLANON 68 MG IMPLANTS pharmaceutical product. The contract is a firm fixed-price delivery order that does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite...
This federal contract award, valued at $28,587.60, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the recurring medical supply needs of military health facilities. The contract is a delivery order awarded under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price valued at $35,734.50. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS to support the recurring medical supply needs of military health facilities. This contract is part of a larger indefinite delivery contract (IDC) with DMS...
This federal contract award, valued at $3,775.08, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive device. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
This federal contract award, valued at $4,288.14, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product, with a performance period ending on September 26, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,288.14, is for the delivery of NEXPLANON 68 MG IMPLANTS to the DLA's Medical Supply Chain division. The contract is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the...
This federal contract award is for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The $3,573.45 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This federal contract award, valued at $1,388.64, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for 4,567,571,204 units of NEXPLANON 68 MG IMPLANTS, a contraceptive product. The contract is a firm fixed-price award with an ultimate completion date of April 1, 2025. DMS Pharmaceutical Group Inc. also holds a significant single-award Indefinite...
This federal contract award, valued at $4,165.86, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a specialized pharmaceutical product, with a period of performance through April 16, 2025. The contract is a firm fixed-price delivery order and is not associated with any set-aside designation. DMS Pharmaceutical Group...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB24FPRD6
    Delivery Order

This federal contract award, valued at $34,305.12, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order contract for NEXPLANON 68 MG IMPLANTS. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation.

Generated 11/4/24, 9:14 AM